Wednesday, May 14, 2025
HomeIndustriesHealthcare

Healthcare

Diadem Announces Publication of Clinical Study Confirming Its AlzoSure Predict Blood Test Can Accurately Predict Progression to Alzheimer’s Disease Six Years Before Diagnosis

Diadem SpA announced publication of the results of a clinical validation study of its AlzoSure Predict prognostic blood test for Alzheimer's disease (AD). The...

A Breakthrough in Biopharmaceutical Protein Production; Leniobio Announces a New Proprietary Cell Line Devoid of Plant Glycans

German life science biotech firm, LenioBio GmbH, announced the generation of a novel plant glycan knockout cell line that will increase the versatility and...

Tethis Launches See.d, the First Fully Automated, Standardized Pre-analytical Platform for Comprehensive Liquid Biopsy Testing

Tethis S.p.A announces the release of See.d, the first universal blood sample preparator for liquid biopsy analysis. This innovative technology performs a completely automated...

Novo Holdings Portfolio Company F2G Enters Strategic Collaboration With Shionogi to Commercialise Its New Antifungal Agent Olorofim in Europe and Asia

Novo Holdings A/S, a leading international life sciences investor, announces that its portfolio company F2G Ltd. (F2G) has entered into a strategic collaboration with...

Atamyo Therapeutics Announces Significant Milestones for ATA-100 and ATA-200, its Gene Therapy Programs to Treat Limb-Girdle Muscular Dystrophy 2I/R9 and 2C/R5

Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting neuromuscular diseases, announced multiple major milestones for ATA-100 and ATA-200,...
0FansLike
0FollowersFollow
spot_img

Hot Topics